Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6891-6899

  Doubrovina, Ekaterina S ^a   Doubrovin, Mikhail M ^a   Vider, Elena ^a   Sisson, Richard B ^a   O'Reilly, Richard J ^a   Dupont, Bo ^a   Vyas, Yatin M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CC CHEMOKINE RECEPTOR 7; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GROWTH INHIBITOR; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 8; LIGAND; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICA PROTEIN; MICB ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; NKG2 PROTEIN; PROTEIN; PROTEIN NKP44; PROTEIN P44; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CULTURE; CELL LINE; CELLULAR IMMUNITY; COCULTURE; COLON ADENOCARCINOMA; COLON TUMOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOSURVEILLANCE; IN VITRO STUDY; INTERNALIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SCID MOUSE; SOLUBILITY; T LYMPHOCYTE; TRANSPLANTATION; TUMOR ESCAPE; UPREGULATION; VIRUS; XENOGRAFT;

EID: 0347627712     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6891     Document Type: Article

References (54)

1. Biron. C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
2. Diefenbach, A., and D. H. Raulet. 2002. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol. Rev. 188:9.
3. Kiessling, R., G. Bataillon, E. W. Lamon, and E. Klein. 1974. The lymphocyte response to primary Moloney sarcoma virus tumors: Definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts. Int. J. Cancer 14:642.
4. Herberman, R. B., M. E. Nunn, and D. H. Lavrin. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16:216.
5. Ljunggren, H. G., and K. Karre. 1990. In search of the "missing self" MHC: Molecules and NK cell recognition. Immunol. Today. 11:237.
6. Groh, V., S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93:12445.
7. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16, and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123.
8. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119.
9. Cerwenka, A., A. B. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Phillips, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721.
10. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday. 2001. Regulation of cutaneous malignancy by γδ T cells. Science 294:605.
11. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier. and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible M1CA. Science 285: 727.
12. Diefenbach, A., E. Tomasello, M. Lucas, A. M. Jamieson, J. K. Hsia, E. Vivier, and D. H. Raulet. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Natl. Immunol. 3:1142.
13. Gilfillan, S., E. L. Ho, M. Cella, W. M. Yokoyama, and M. Colonna. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3:1150.
14. Diefenbach, A., E. R. Jensen, A. M. Jamieson, and D. H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165.
15. Cerwenka, A., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class 1-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98:11521.
16. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255.
17. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419:734.
18. Sivori, S., S. Parolini, E. Marcenaro, R. Castriconi, D. Pende, R. Millo, and A. Moretta. 2000. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J. Neuroimmunol. 107:220.
19. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055.
20. Sivori, S., M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta. 1997. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186:1129.
21. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukocyte Biol. 71:173.
22. +NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166:6477.
23. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217.
24. Robertson, M. J., B. T. Williams, K. Christopherson, Z. Brahmi, R. Hromas. 2000. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cell. Immunol. 199:8.
25. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, and R. M. Strieter. 1991. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174:1355.
26. Arenberg, D. A., M. P. Keane, B, DiGiovine, S. L. Kunkel, S. B. Morris, Y. Y. Xue, M. D. Burdick, M. C. Glass, M. D. Iannettoni, and R. M. Strieter. 1998. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 102:465.
27. Inoue, K., J. W. Slaton, B. Y. Eve, S. J. Kim, P. Perrotte, M. D. Balbay, S. Yano, M. Bar-Eli, R. Radinsky, C. A. Pettaway, and C. P. Dinney. 2000. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res. 60:2290.
28. Bendre, M. S., D. Gaddy-Kurten, T. Mon-Foote, N. S. Akel, R. A. Skinner, R. W. Nicholas, and L. J. Suva. 2002. Expression of Interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res. 62:5571.
29. Li, A., S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh. 2003. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinase production and regulated angiogenesis. J. Immunol. 170:3369.
30. Van den Steen, P. E., P. Proost, A. Wuyts, J. Van Damme, and G. Opdenakker. 2000. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RAN-TES and MCP-2 intact. Blood 96:2673.
31. Vihinen, P., and V. M. Kahari. 2002. Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets, Int. J. Cancer 99:157.
32. r 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res. 51:439.
33. MacDougall, J. R., M. R. Bani, Y. Lin, J. Rak, and R. S. Kerbel. 1995. The 92-kDa gelatinase B is expressed by advanced stage melanoma celIs cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res. 55:4174.
34. Salih, H. R., H. G. Rammensee, and A. Steinle. 2002. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169:4098.
35. Vyas, Y. M., K. M. Mehta, M. Morgan, H. Maniar, L. Butros, S. Jung, J. K. Burkhardt, and B. Dupont. 2001. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated non-cytolytic and cytolytic interactions. J. Immunol. 167:4358.
36. Yan, Y., O. Salomon, J. McGuirk, D. Dennig, J. Fernandez, C. Jagiello, H. Nguyen, N. Collins, P. Steinherz, and R.J. O'Reilly, 1996. Growth pattern and clinical correlation of subcutaneonsly inoculated human primary acute leukemias in severe combined immunodeficiency mice. Blood 88:3137.
37. Basoglu, M., M. I. Yildirgan, S. Taysi, I. Yilmaz, A. Kiziltunc, A. A. Balik, F. Celebi, and S. S. Atamanalp. 2003. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer. J. Surg. Oncol. 83:180.
38. Salih, H., H. Antropius, F. Gieseke, S. Z. Lutz, L. Kanz, H. G. Rammensee, and A. Steinle. 2003. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102:1389.
39. Zou, Y., and P. Stastny. 2002. Altematively spliced forms of MICA and MICB lacking exon 3 in a human cell line and evidence of presence of similar RNA in human peripheral blood mononuclear cells. Immunogenetics 54:671.
40. Feniger-Barish, R., M. Ran, A. Zaslaver, and A. Ben-Baruch. 1999. Differential modes of regulation of cxc chemokine-induced intemalization and recycling of human CXCR1 and CXCR2. Cytokine 11:996.
41. +-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling. Blood 95:1551.
42. Richardson, R. M., R. DuBose, H. Ali, E. Tomhave, B. Haribabu, and R. Snyderman. 1995. Regulation of human interleukin-8 receptor A: Identification of a phosphorylation site involved in modulating receptor function. Biochemistry 34:14193.
43. Costello, R. T., S. Sivori, E. Marcenaro, M. Lafage-Pochitaloff, M. J. Mozziconacci, D. Reviron, J. A. Gastaut, D. Pende, D. Olive, and A. Moretta. 2002. Defective expression and function of natural killer cell: Triggering receptors in patients with acute myeloid leukemia. Blood 99:3661.
44. Bouchon A., C. Hemandez-Munain, M. Cella, and M. Colonna. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:1111.
45. Ogasawara. K., J. A. Hamerman, H. Hsin, S. Chikuma, H. Bour-Jordan, T. Chen, T. Pertel, C., Carnaud, J. A. Bluestone, and L. L. Lanier., 2003. Impairment of NK Cell Function by NKG2D Modulation in NOD Mice. Immunity 18:41.
46. Castriconi, R., C. Cantoni, M. Della Chiesa, M. Vitale, E. Marcenaro, R. Conte, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2003. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100:4120.
47. Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29:117.
48. Kim, S. J., J. H. Kehrl, J. Burton, C. L. Tendler, K. T. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, M. B. Sporn, and A. B. Roberts. 1990. Transactivation of the transforming growth factor β (TGF-β1) gene by human T lymphotropic virus type I tax: A potential mechanism for the increased production of TGF-β1 in adult T cell leukemia. J. Exp. Med. 172:121.
49. Berking, C., R. Takemoto, H. Schaider, L. Showe, K. Satyamoorthy, P. Robbins, and M. Herlyn. 2001. Transforming growth factor-β1 increases survival of human melanoma through stroma remodeling. Cancer Res. 61:8306.
50. Brodsky, F. M., L. Lem, A. Solache, E. M. Bennett. 1999. Human pathogen subversion of antigen presentation. Immunol. Rev. 168:199.
51. Reddehase, M. J. 2002. Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:831.
52. Hayday, A., E. Theodoridis, E. Ramsburg, and J. Shires. 2001. Intraepithelial lymphocytes: Exploring the Third Way in immunology. Nat. Immunol. 2:997.
53. Jamieson, A. M., A. Diefenbach, C. W. McMahon, N. Xiong, J. R. Carlyle, D. H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17:19.
54. Wu, J., V. Groh, T. Spies. 2002. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells. J. Immunol. 169:1236.